42 CFR 2.36: Disclosures to prescription drug monitoring programs.
Where this section sits in the code
- Title 42—Public Health
- CHAPTER I—PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES
- SUBCHAPTER A—GENERAL PROVISIONS
- PART 2—CONFIDENTIALITY OF SUBSTANCE USE DISORDER PATIENT RECORDS
- Subpart C—Uses and Disclosures With Patient Consent
A part 2 program or other lawful holder is permitted to report any SUD medication prescribed or dispensed by the part 2 program to the applicable state prescription drug monitoring program if required by applicable state law. A part 2 program or other lawful holder must obtain patient consent to a disclosure of records to a prescription drug monitoring program under § 2.31 prior to reporting of such information.
Collected 2026-08-27T02:26:11Z. Source file · JSON